Private company

REST EZ Inc.

REST EZ Inc. is an American pharmaceutical preparations company based in West Jordan.1

Last updated Oct 21, 2026.

Overview

-$14.7KNet income, fiscal 20262
  • IndustryPharmaceutical Preparations1
  • HeadquartersRiverton, Utah1
  • Incorporated inWY3
  • Business address1398 West Mason Hollow Drive, Riverton, Ut 840653
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3
  • Legal formCorporation

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-100.0%Revenue growth, 20254
-2633.3%Return on equity2

Financial statements

Revenue5674$0 in 2025
0$200.0K$400.0K$600.0K2021: $105.0K$105.0K20212022: $519.4K$519.4K2022+395%2023: $0$020232024: $5.0K$5.0K20242025: $0$02025
Gross profit5674$0 in 2025
0$100.0K$200.0K$300.0K2021: $0$020212022: $250.4K$250.4K20222023: $0$020232024: $2.5K$2.5K20242025: $0$02025
Operating income56742-$7.9K in 2025−37% since 2021
-$600.0K-$400.0K-$200.0K0$200.0K$400.0K2021: -$12.6K-$12.6K20212022: $223.6K$223.6K20222023: -$418.4K-$418.4K20232024: -$19.4K-$19.4K2024−95%2025: -$7.9K-$7.9K2025−59%
Net income5742-$7.9K in 2025−66% since 2021
-$600.0K-$400.0K-$200.0K0$200.0K2021: -$23.2K-$23.2K20212022: $172.0K$172.0K20222023: -$428.7K-$428.7K20232024: -$19.4K-$19.4K2024−95%2025: -$7.9K-$7.9K2025−59%
Fiscal year202020212022202320242025
Revenue$105.0K5$519.4K6$07$5.0K4$04
Cost of revenue$105.0K5$269.1K6$07$2.5K4$04
Gross profit$05$250.4K6$07$2.5K4$04
Operating expenses$26.8K6$418.4K7$21.8K4$7.9K2
Operating income-$12.6K5$223.6K6-$418.4K7-$19.4K4-$7.9K2
Interest$10.6K5$10.0K6$10.3K7$07$04
Income before tax$213.7K6-$428.7K7$04$04
Income tax$05$41.7K6$07$04$04
Net income-$23.2K5$172.0K7-$428.7K4-$19.4K2-$7.9K2
Earnings per share$0.005$0.016-$0.027$0.004$0.002
Earnings per share (diluted)$0.005$0.016-$0.027$0.004$0.002
Shares (weighted, basic)20.0M shares620.0M shares720.0M shares427.5M shares2
Shares (weighted, diluted)20.0M shares620.0M shares720.0M shares427.5M shares2

Compare REST EZ Inc. with another company

What it owns

What REST EZ Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$3004 Mar 31, 2025$04 Mar 31, 2024

Inventory

ItemLatestA year beforeChange
Inventory, total$04 Mar 31, 2025$04 Mar 31, 2024
Finished goods$02 Mar 31, 2026$02 Mar 31, 2025

Properties, in its own words

The Company uses a corporate office located at: 8928 Black Pine Street West Jordan, Utah 84088. This facility is being provided to the Company free of charge by the Company’s CEO. The facility is provided free of charge until the company needs additional space to store inventory of over 100,000 bottles. The Company does not currently require storage space for inventory over 100,000 bottles. There are currently no proposed programs for renovations, improvements or developments of the facility currently in use.

Item 2 of the 10-K filed Aug 28, 2026.11

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorDylan Carson named Jul 7, 202512
  • Executive OfficerBrandon Sosa named Jan 6, 2023 to Dec 20, 202313

Timeline

  1. Jul 10, 20258-K Other events14
  2. Jul 9, 20258-K Other events15
  3. Sep 26, 20238-K Change of auditor16
  4. Jun 21, 20228-K Change of auditor17
  5. Jan 31, 20228-K Change of auditor18

Filings

34 filings to the SEC since October 2021: 6 annual reports, 14 quarterly reports, 5 major events, 3 private raises, 6 other. The latest 20:

  1. Aug 28, 202610-K ANNUAL REPORT EDGAR
  2. Jun 30, 2026NT 10-K EDGAR
  3. Feb 10, 202610-Q EDGAR
  4. Dec 23, 202510-Q EDGAR
  5. Dec 23, 202510-Q EDGAR
  6. Dec 16, 202510-K EDGAR
  7. Jul 10, 20258-K EDGAR
  8. Jul 9, 20258-K REST EZ 8-K EDGAR
  9. Jul 7, 2025D EDGAR
  10. Apr 25, 202510-Q EDGAR
  11. Apr 25, 202510-Q EDGAR
  12. Apr 25, 202510-Q EDGAR
  13. Feb 13, 202510-K EDGAR
  14. Mar 7, 202410-Q EDGAR
  15. Jan 16, 202410-Q EDGAR
  16. Dec 20, 2023D EDGAR
  17. Sep 29, 2023PRE 14C EDGAR
  18. Sep 26, 202310-Q EDGAR
  19. Sep 26, 20238-K EDGAR
  20. Sep 13, 202310-K/A EDGAR

The 34 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$367.5K 2019–2025
Money received by yearMoney received by year, 2019–2025: $367.5K in all. Private raises (Form D) $367.5K.$0$50K$100K$150K2019 · Private raises (Form D): $137.5K20192021 · Private raises (Form D): $80.0K202120232025 · Private raises (Form D): $150.0K2025
Figures by year
YearPrivate raises (Form D)Total
2025$150.0K$150.0K
2021$80.0K$80.0K
2019$137.5K$137.5K

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Jun 1, 2025Raised $150,000 in a private offering of debt12 Form D: named in the filing: Dylan Carson Form D
  2. Aug 4, 2021Raised $80,000 in a private offering of equity19 Form D: 64 investors so far Form D
  3. Mar 29, 2019Raised $137,500 in a private offering of debt13 Form D: named in the filing: Brandon Sosa Form D

SEC filer profile

How REST EZ Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARREST EZ Inc.1
  • CIK0001733861
  • Employer ID (EIN)82-426898211
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; not a shell company11
  • Incorporated inWyoming11
  • Fiscal year endsMarch 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address1398 West Mason Hollow Drive, Riverton, UT 840651
  • Phone801-300-25421
  • Shares outstanding60,000,000 shares as of Mar 31, 202611
  • Public float$250.0K as of Mar 31, 202611
  • AuditorDylanFloyd Accounting & Consulting, Newhall, California PCAOB ID 2738; no auditor attestation of internal control over financial reporting11
  • On EDGAR sinceMar 15, 20181
  • Filings45 in all: 10-Q (15), 10-K (5), 8-K (5), D (4), CORRESP (3), NT 10-K (2), NT 10-Q (2), S-1/A (2)1
    All 14 form types

    UPLOAD (2), 10-K/A (1), 8-A12G (1), EFFECT (1), PRE 14C (1), S-1 (1)

  • Latest filingsAnnual report (10-K) Aug 28, 2026
    Quarterly report (10-Q) Feb 10, 2026
    Latest 8-K (8-K) Jul 10, 2025

Securities registered for trading

ClassSymbolExchange
CommonRTEZNONE

From the cover page of the 10-K filed Aug 28, 2026 (Section 12(b) of the Exchange Act).11

Risk factors and legal proceedings

The risks REST EZ Inc. names in Item 1A of its 10-K filed Aug 28, 2026: 15 risks under these headings, as written.11

  • Risks Related to Our Business
  • Side effects of the product.
  • There are many inherent risks and difficulties in introducing a new product to the marketplace.
  • We may not be able to build our brand awareness.
  • The Company’s current business operations rely heavily upon our key wholesalers, retailers, and sole officers, directors, and founders.
  • The company’s future growth may require recruitment of qualified employees.
  • Product sales were for several major customers.
  • We may incur significant costs to be a public company to ensure compliance with U.S. corporate governance and accounting requirements, and we should be able to absorb such costs.
  • The lack of public company experience of the company’s sole officer and director could adversely impact our ability to comply with the reporting requirements of U.S. securities laws.
  • The Company’s operating results may fluctuate due to factors which are not within its control.
  • We may never pay any dividends to shareholders.
  • Our controlling security holder may take actions that conflict with your interests.
The other 4 risks
  • The offering price of the common stock was arbitrarily determined and therefore should not be used as an indicator of the future market price of the securities. Therefore, the offering price bears no relationship to our actual value and may make our shares difficult to sell.
  • You may experience dilution of your ownership interest because of the future issuance of additional shares of our common stock.
  • Our common stock is on OTCIQ, which may be subject to restrictions on marketability.
  • There is no assurance of a public market or that our common stock will ever trade on a recognized exchange. Therefore, you may be unable to liquidate your investment in our stock.

Legal proceedings

From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business.

We are not currently a party in any legal proceeding or governmental regulatory proceeding nor are we currently aware of any pending or potential legal proceeding or governmental regulatory proceeding proposed to be initiated against us that would have a material adverse effect on us or our business.

The opening of Item 3, Legal Proceedings.11